Browse by CSHL Author

[up] Up a level
Group by: Item Type | No Grouping
Number of items at this level: 6.

Barth, N. D., Subiros-Funosas, R., Mendive-Tapia, L., Duffin, R., Shields, M. A., Cartwright, J. A., Henriques, S. T., Sot, J., Goñi, F. M., Lavilla, R., Marwick, J. A., Vermeren, S., Rossi, A. G., Egeblad, M., Dransfield, I., Vendrell, M. (August 2020) A fluorogenic cyclic peptide for imaging and quantification of drug-induced apoptosis. Nat Commun, 11 (1). p. 4027. ISSN 2041-1723

Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., Upadhyay, P., Uyeminami, D. L., Pommier, A., Kuttner, V., Bruzas, E., Maiorino, L., Bautista, C., Carmona, E. M., Gimotty, P. A., Fearon, D. T., Chang, K., Lyons, S. K., Pinkerton, K. E., Trotman, L. C., Goldberg, M. S., Yeh, J. T., Egeblad, M. (September 2018) Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science, 361 (6409). ISSN 0036-8075

Ebine, K., Kumar, K., Pham, T. N., Shields, M. A., Collier, K. A., Shang, M., DeCant, B. T., Urrutia, R., Hwang, R. F., Grimaldo, S., Principe, D. R., Grippo, P. J., Bentrem, D. J., Munshi, H. G. (September 2018) Interplay between interferon regulatory factor 1 and BRD4 in the regulation of PD-L1 in pancreatic stellate cells. Sci Rep, 8 (1). p. 13225. ISSN 2045-2322

Shields, M., Maguin, P., Giuliano, C., Dallas, S., Wilkinson, J. E., Egeblad, M. (May 2018) Lysyl oxidases suppress pancreatic cancer progression and inhibit FAK and ERK signaling. Cancer Research, 78 (10 Sup). pp. 76-77. ISSN 0008-5472

Ruscetti, M., Leibold, J., Bott, M. J., Shields, M., Chen, C. C., Fennell, M., Chen, H. C., Baslan, T., Salgado, N. R., Manchado, E., Low, V., Poirier, J. T., Rudin, C. M., de Stanchina, E., Egeblad, M., Sherr, C. J., Lowe, S. W. (May 2018) Targeted therapy-induced senescence enhances immune surveillance of KRAS mutant lung cancers. Cancer Research, 78 (10 Sup). ISSN 0008-5472

Shields, M. A., Maguin, P., Kumar, P., Dallas, S. L., Egeblad, M. (July 2015) Lysyl oxidases are poor therapeutic targets in pancreatic cancer. Cancer Research, 75 (Supple). A43. ISSN 0008-5472

This list was generated on Sat Nov 23 16:56:41 2024 EST.